
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Using the ICH estimand framework to improve the interpretation of treatment effects in internet interventions - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE533AD08AF33413053AD000311ED735.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="npjdigitmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368201/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="NPJ Digital Medicine">
<meta name="citation_title" content="Using the ICH estimand framework to improve the interpretation of treatment effects in internet interventions">
<meta name="citation_author" content="Manuel Heinrich">
<meta name="citation_author_institution" content="Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany">
<meta name="citation_author" content="Pavle Zagorscak">
<meta name="citation_author_institution" content="Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany">
<meta name="citation_author" content="Johannes Bohn">
<meta name="citation_author_institution" content="Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany">
<meta name="citation_author" content="Christine Knaevelsrud">
<meta name="citation_author_institution" content="Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany">
<meta name="citation_author_institution" content="German Center for Mental Health (DZPG), partner site Berlin-Potsdam, Berlin-Potsdam, Germany">
<meta name="citation_author" content="Lars Schulze">
<meta name="citation_author_institution" content="German Center for Mental Health (DZPG), partner site Berlin-Potsdam, Berlin-Potsdam, Germany">
<meta name="citation_author_institution" content="Division of Clinical Psychology and Psychotherapy, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="8">
<meta name="citation_firstpage" content="535">
<meta name="citation_doi" content="10.1038/s41746-025-01936-0">
<meta name="citation_pmid" content="40835721">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368201/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368201/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368201/pdf/41746_2025_Article_1936.pdf">
<meta name="description" content="The ICH E9(R1) Addendum on Estimands and Sensitivity Analysis provides a framework for defining the treatment effect a trial intends to estimate—the estimand. The addendum is widely adopted in pharmaceutical research. However, it remains ...">
<meta name="og:title" content="Using the ICH estimand framework to improve the interpretation of treatment effects in internet interventions">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The ICH E9(R1) Addendum on Estimands and Sensitivity Analysis provides a framework for defining the treatment effect a trial intends to estimate—the estimand. The addendum is widely adopted in pharmaceutical research. However, it remains ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368201/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12368201">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41746-025-01936-0"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41746_2025_Article_1936.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368201%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12368201/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12368201/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368201/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-npjdigitmed.jpg" alt="NPJ Digital Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to NPJ Digital Medicine" title="Link to NPJ Digital Medicine" shape="default" href="https://www.nature.com/npjdigitalmed/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">NPJ Digit Med</button></div>. 2025 Aug 20;8:535. doi: <a href="https://doi.org/10.1038/s41746-025-01936-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41746-025-01936-0</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22NPJ%20Digit%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22NPJ%20Digit%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22NPJ%20Digit%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22NPJ%20Digit%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Using the ICH estimand framework to improve the interpretation of treatment effects in internet interventions</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heinrich%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Manuel Heinrich</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Manuel Heinrich</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heinrich%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Manuel Heinrich</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zagorscak%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Pavle Zagorscak</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Pavle Zagorscak</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zagorscak%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pavle Zagorscak</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bohn%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Johannes Bohn</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Johannes Bohn</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bohn%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Johannes Bohn</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Knaevelsrud%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Christine Knaevelsrud</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Christine Knaevelsrud</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany </div>
<div class="p">
<sup>2</sup>German Center for Mental Health (DZPG), partner site Berlin-Potsdam, Berlin-Potsdam, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Knaevelsrud%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christine Knaevelsrud</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schulze%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Lars Schulze</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Lars Schulze</span></h3>
<div class="p">
<sup>2</sup>German Center for Mental Health (DZPG), partner site Berlin-Potsdam, Berlin-Potsdam, Germany </div>
<div class="p">
<sup>3</sup>Division of Clinical Psychology and Psychotherapy, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schulze%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lars Schulze</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Division of Clinical-Psychological Intervention, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany </div>
<div id="Aff2">
<sup>2</sup>German Center for Mental Health (DZPG), partner site Berlin-Potsdam, Berlin-Potsdam, Germany </div>
<div id="Aff3">
<sup>3</sup>Division of Clinical Psychology and Psychotherapy, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 27; Accepted 2025 Aug 6; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12368201  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40835721/" class="usa-link">40835721</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">The ICH E9(R1) <em>Addendum on Estimands and Sensitivity Analysis</em> provides a framework for defining the treatment effect a trial intends to estimate—the estimand. The addendum is widely adopted in pharmaceutical research. However, it remains underutilized in trials investigating internet-based interventions (IBIs). This manuscript introduces the addendum to IBI researchers. It concludes that estimands are essential to improve the interpretability, relevance, and validity of effect estimates derived in IBI trials.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Outcomes research, Clinical trial design</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">To ensure that randomized controlled trials of (non-) digital (mental) health interventions yield informative results, researchers need to define the intended substantive meaning of the treatment effect they intend to estimate: the <em>estimand</em><sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. An estimand forms the basis for designing trials that allow collecting data needed to answer the clinical question. An estimator (i.e., a statistical procedure) that is aligned with the estimand is used to summarize the data and derive an estimate that accurately quantifies the estimand<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>.</p>
<p id="Par3">The ICH E9(R1) <em>Addendum on Estimands and Sensitivity Analyses</em>, developed by regulatory authorities in the pharmaceutical industry, was published to facilitate the process of defining estimands<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Essentially, it recommends three steps<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>:</p>
<ol class="list" style="list-style-type:decimal">
<li><p id="Par4">Define the estimand attributes: population, endpoint, treatment, and statistical summary measure<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>.</p></li>
<li><p id="Par5">Identify possible intercurrent events (ICEs): events that occur after treatment initiation and affect either the interpretation or availability of measurements relevant to answering the clinical question (e.g., treatment discontinuation)<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>.</p></li>
<li><p id="Par6">Choose strategies for dealing with ICEs that ensure that the estimate remains aligned with the estimand<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>.</p></li>
</ol>
<p id="Par7">Pharmacology researchers have adopted the addendum; numerous publications explained, refined, and illustrated its application<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. However, the addendum is underutilized in Internet-based interventions (IBIs: interventions that provide individuals access to evidence-based psychotherapeutic techniques in a digital format) research, despite its potential to (1) enhance the interpretability of IBI studies<sup><a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup> and (2) its recognition in the European Medicines Agency (EMA) guidelines on depression trials<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup> and the updated CONSORT guidelines<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. This manuscript provides an overview of the estimand framework for IBI researchers, particularly clinical psychologists, psychiatrists, and non-statistical professionals who play a key role in trial design and implementation. We outline key assumptions and provide resources for statistical details.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Motivating example</h2>
<p id="Par8">Two trials evaluate the same IBI for depression. They use the same inclusion criteria, recruit from routine care, employ a waitlist control, and use self-reported depressive symptoms 8 weeks after randomization as the endpoint.</p>
<p id="Par9"><em>Trial A</em> assessed depressive symptoms weekly, but only while patients used the IBI. Thus, the endpoint is missing for individuals who discontinued treatment. Trial A replaces missing endpoints using multiple imputations with depression scores collected while individuals used the IBI as auxiliary information. <em>Trial B</em> collects the endpoint from <em>all</em> patients, even if they discontinued the IBI. Thus, Trial B has no missing values.</p>
<p id="Par10">Since neither study defines what treatment effect they intend to estimate or describes the assumptions underlying their approaches, the reader must infer the meaning of the estimated treatment effect from how the data were collected and analyzed<sup><a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. It becomes evident that the two trials answer <em>different</em> clinical questions.</p>
<p id="Par11">Since the imputation model in Trial A only knows how the symptoms develop while individuals are on treatment, it imputes the missing values of discontinuers as if they continued the treatment<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. Trial A estimates a treatment effect for a <em>hypothetical scenario</em> in which one has found a “magical” measure to get all non-adherers to adhere<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. However, the assumption that individuals who discontinued IBI have similar symptom trajectories to those who completed it, especially if discontinuation is related to the intervention, worsening of symptoms, or other characteristics that distinguish discontinuers from those who adhere, is unrealistic. Trial A appears to be valid. However, not collecting endpoints from discontinuers can be a trial-related flaw that may lead to overestimated treatment effects that do not generalize to clinically relevant contexts.</p>
<p id="Par12">Trial B collects the endpoint from all patients, regardless of adherence. It targets the symptom change in a <em>real-world scenario</em> in which treatment discontinuation occurs.</p></section><section id="Sec3"><h2 class="pmc_sec_title">The estimand, its attributes, and intercurrent events</h2>
<p id="Par13">The estimand is the central concept of the ICH E9(R1) addendum. An <em>estimand</em> is a systematic description of the effect researchers want to quantify<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. The addendum recommends defining the estimand along five attributes<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>.</p>
<ul class="list" style="list-style-type:disc">
<li><p id="Par14"><em><span class="text-underline">Treatment:</span></em> A complete description of the treatment regimen for all study arms is required, including all digital (e.g., number of modules, intended dosage) and non-digital components (e.g., whether concurrent antidepressant use is permitted, emergency procedures). It is incorrect to equate the treatment with the IBI; the IBI is typically just the major ingredient of a comprehensive treatment regimen.</p></li>
<li><p id="Par15"><em><span class="text-underline">Population:</span></em> The eligibility criteria define the target population<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Baseline characteristics inform how well the sample represents it. The addendum highlights the possibility of focusing on principal strata (see section on <em>principal strata</em>)<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>.</p></li>
<li><p id="Par16"><em><span class="text-underline">Endpoint:</span></em> The endpoint is the variable collected to quantify the treatment effect, including the assessment time and modality<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Endpoints may be questionnaire scores, diagnostic classifications, or composite variables<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>.</p></li>
<li><p id="Par17"><em><span class="text-underline">Population-level summary:</span></em> The population-level summary is a statistical measure calculated to quantify the treatment effect<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. IBI trials are typically interested in differences in mean symptom scores or responder rates.</p></li>
</ul>
<p id="Par18">Table <a href="#Tab1" class="usa-link">1</a> summarizes some considerations for defining these attributes in IBI trials. These aspects are not IBI-specific, but important due to the nature of IBIs.</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Aspects related to the four main attributes of the estimand in trials investigating IBIs</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr><td colspan="1" rowspan="1"><strong>Treatment</strong></td></tr>
<tr><td colspan="1" rowspan="1">
<p>►<em>Describe all components of the IBI</em>. IBIs are treatment packages that differ in several dimensions, such as (a) the theoretical foundation, (b) the number of modules, (c) the psychotherapeutic techniques used, (d) the sequence and/or the timing of treatment modules, (e) the rules for how clients access new content, (f) the amount and type of guidance, or (g) the type of personalization. Trial protocols should describe all components. This description should also include aspects of technical implementation, such as (i) the type of platform, (ii) the form of the application (mobile vs. web-based), and (iii) the nudging mechanisms used (e.g., gamification, reminders).</p>
<p>►<em>Define what “being treated” means</em>. In principle, various meaningful definitions exist, such as (a) gaining access to the treatment material or (b) completing all or a certain proportion of the modules. However, IBI participants often choose the dose and intensity of the IBI treatment for themselves. This IBI characteristic makes some estimands more plausible (e.g., the treatment effect of individuals gaining access to an IBI with a non-standardized and self-selected dose; <em>treatment policy strategy</em>) than others (e.g., the effect that would have been observed with perfect adherence). Moreover, protocol deviations are difficult to define and assess. This also concerns treatment discontinuation. For example, in an IBI trial where participants enter modules sequentially, a treatment could be considered discontinued if individuals stop logging in to the modules. However, in other IBIs, individuals decide for themselves how many and which modules they use; defining discontinuation and handling it appropriately can become much more challenging. Consequently, many IBI trials likely focus on the effect of making an IBI accessible.</p>
<p>►<em>Define if the treatment regimen under investigation accepts treatments in parallel</em>. IBIs are low-threshold interventions that are not regularly accompanied by visits to study centers. Therefore, there is little control over what individuals do in parallel. In the eligibility criteria, IBI often limits the parallel treatments with which participants are allowed to enter the trial. However, the use of parallel treatments initiated <em>after</em> randomization is usually not restricted. Consequently, it should be explicitly stated which parallel treatments are allowed. In most instances, especially in clinical samples, all parallel treatments are allowed and a <em>treatment policy strategy</em> (e.g., collect data even if individuals use treatments in parallel) will be employed. However, this should be stated explicitly, and the frequency and intensity of parallel treatments should be assessed and reported.</p>
</td></tr>
<tr><td colspan="1" rowspan="1"><strong>Population</strong></td></tr>
<tr><td colspan="1" rowspan="1">►<em>Excluded post-hoc changes the population attribute</em>. IBI trials may exclude randomized patients post hoc (<em>modified</em> intention-to-treat analysis<sup><a href="#CR53" class="usa-link" aria-describedby="CR53">53</a></sup>). In IBI trials, this may concern individuals who have at least started working with the program or completed at least two modules. However, such exclusions change the population attribute, may introduce bias<sup><a href="#CR54" class="usa-link" aria-describedby="CR54">54</a></sup>, and must be justified. Consider the exclusion of individuals who commit suicide immediately after randomization. This exclusion is only justifiable if the researcher is absolutely certain that the observed adverse event has nothing to do with the outcome of the randomization (e.g., if individuals commit suicide because they were assigned to a treatment arm that they consider useless); if applied inappropriately, one throws away evidence against the specific treatment regimen that caused the adverse event. This also applies to per-protocol analyses that define strata based on observed completion status (see Table <a href="#Tab3" class="usa-link">3</a>).</td></tr>
<tr><td colspan="1" rowspan="1"><strong>Endpoint</strong></td></tr>
<tr><td colspan="1" rowspan="1">
<p>►<em>Consider the time-point of assessment as an endpoint attribute</em>. Describe when the endpoint will be assessed. If possible, define a time frame that is considered acceptable and how observations collected outside this time frame are handled.</p>
<p>►<em>Discuss whether linking measurement to progress in the IBI is sensible</em>. IBI trials may align assessments with specific events, such as the start of a new module or completion of all modules. However, this creates a correlation between adherence and endpoint availability, which raises methodological challenges. First, assessment times can vary widely when participants complete the program at their own pace, making it difficult to control for time effects. Second, if the assessment of the outcome is linked to the completion of the intervention, participants control when the endpoint is assessed; for example, participants may complete the endpoint assessment when they feel ready rather than at the intended point in time<sup><a href="#CR55" class="usa-link" aria-describedby="CR55">55</a></sup>. If the missing assessments at the time of interest depend on the endpoint itself, the estimate could be biased<sup><a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>,<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a></sup>.</p>
<p>►<em>Assessing endpoints outside the IBI could be useful</em>. While conventional clinical trials often involve on-site assessments conducted in study centers, this is less common in IBI trials. IBIs may assess the endpoint within the application. However, this can result in a correlation between endpoint availability and adherence. Especially if no information is available about how endpoints developed among individuals who discontinued the IBI, problems can arise. Researchers must rely on a hypothetical strategy that imposes assumptions about the post-ICE symptom development. Therefore, alternative assessment modalities (e.g., telephone interviews) for the primary endpoint should be considered. This method allows for standardization of the assessment time-point for all participants, reduces reliance on IBI participation patterns, and could increase the sense of commitment to the evaluations.</p>
<p>►<em>Apply the same principles to endpoints different from symptom change</em>. In some studies, other variables, such as treatment discontinuation, could be the endpoints. To derive meaningful treatment effects, the same principles discussed for defining appropriate estimands should be applied.</p>
</td></tr>
<tr><td colspan="1" rowspan="1"><strong>Statistical summary measures</strong></td></tr>
<tr><td colspan="1" rowspan="1">
<p>► <em>Select an effect size measure that is aligned with the estimand</em>. If a trial is concerned with the mean difference, the statistical summary measure should reflect this mean difference. Therefore, specifying effect sizes that reflect the proportion of variance explained is not informative (e.g., R<sup>2</sup>).</p>
<p>►<em>State your standardizer</em>. Many IBI studies report between-group effects in standardized mean differences. If standardization is required, the standardizer should be specified. For a given mean difference, different standardizers lead to differences in the size of the effect sizes<sup><a href="#CR57" class="usa-link" aria-describedby="CR57">57</a></sup> and, more importantly, represent different estimands<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup>. Standardizing a mean difference by the standard deviation of an untreated reference population has a different meaning than standardizing by the standard deviation of endpoint among all randomized individuals at the endpoint assessment<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup>. It may be useful to report effects in units of the scale, as raw, unstandardized scale values do not depend on the standardizer and are often informative to clinicians.</p>
</td></tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par19">The first four attributes help to identify relevant <em>intercurrent events</em> (ICEs), defined as “events occurring after treatment initiation that affect either [1] the interpretation or [2] the existence of the measurements associated with the clinical question of interest”<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Researchers should anticipate ICEs and discuss how they relate to the four attributes<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. ICEs that result in measurements that misalign with one of the attributes are relevant.</p>
<p id="Par20">Consider a trial that intends to estimate the effect of a scenario in which all individuals use IBI as intended versus no treatment (<em>treatment</em>) among adults with depression (<em>population</em>) in terms of mean differences (<em>population level summary</em>) in PHQ-9 scores 8 weeks after randomization (<em>endpoint</em>). Some patients are expected to discontinue the treatment (<em>ICE</em>). Treatment discontinuation fulfills both criteria of an ICE. First, it affects the interpretation of measurements collected after discontinuation. These measurements reflect the effects of the IBI and everything that happened after discontinuation. Second, measurements necessary to answer the clinical question do not exist for individuals who discontinued the treatment because they did not complete it. To keep the estimate aligned with the estimand, measurements affected by the ICE must be handled properly. This leads to the fifth attribute: <em>the strategies for handling ICE</em>.</p>
<ul class="list" style="list-style-type:disc"><li><p id="Par21"><em><span class="text-underline">Handling ICEs</span></em><span class="text-underline">:</span> Researchers should handle ICEs in a manner that keeps the estimate aligned with the estimand<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. The addendum outlines five strategies, which can be combined: (1) treatment policy strategy, (2) hypothetical strategy, (3) while-on-treatment strategy, (4) composite strategy, and (5) principal strata strategy<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>.</p></li></ul>
<p id="Par22">The addendum highlights the difference between data affected by an ICE and missing data<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. Missing data refers to information that was available but has not been collected. In our example, missing data results when individuals who complete the treatment are not assessed. This is different from data affected by an ICE. In our discontinuation example, the data cannot be collected because the individuals have not completed the IBI.</p></section><section id="Sec4"><h2 class="pmc_sec_title">Strategies to treat intercurrent events</h2>
<p id="Par23">The addendum introduces a fundamental principle: <em>whenever an ICE occurs, the post-ICE data, whether observed or missing, must be handled in a way that aligns with the estimand</em><sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. This section provides a conceptual overview of the five strategies for handling ICEs suggested in the addendum. There is no one-size-fits-all approach. Each strategy entails trade-offs. The appropriate (combined) strategy depends on the clinical question<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. How to handle ICEs should be decided in a comprehensive discussion among all stakeholders<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. All strategies and statistical methods employed to implement the strategies rely on assumptions. These assumptions should be stated<sup><a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. Sensitivity analyses are necessary to assess the robustness of conclusions against violations of these assumptions<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>.</p>
<p id="Par24">We focus on treatment discontinuation (ICE) in a simplified treatment regimen that comprises an IBI as the main treatment ingredient. Participants work with eight modules (one per week) in sequential order. We consider the treatment “discontinued” if the person no longer logs in in spite of not yet having completed all available treatment modules. We use this simplified example to illustrate how different strategies alter the interpretation of the treatment effects. Table <a href="#Tab2" class="usa-link">2</a> illustrates the application of the strategies to other ICEs. Table <a href="#Tab3" class="usa-link">3</a> relates the strategies to concepts widely used in IBI research: (a) the intention-to-treat principle, (b) per-protocol analysis, and (c) efficacy vs. effectiveness trials.</p>
<section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Further examples of applying the strategies to different intercurrent events</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr><td colspan="1" rowspan="1">
<strong>Example 1:</strong> A trial aims to estimate the effect of providing individuals access to an IBI in comparison to no treatment in a scenario where no antidepressants are available. Some individuals in the IBI arm will start antidepressants in parallel (=ICE), initiated outside the trial. For these individuals, an antidepressant-free assessment will not be available. A <em><span class="text-underline">hypothetical strategy</span></em> could be employed to model a scenario in which all participants have completed the IBI without taking antidepressants. Researchers must assume that data from participants who did not start antidepressants is sufficient to model symptom development under the hypothetical scenario. However, individuals who start antidepressants may differ from those who do not initiate antidepressants; covariates to adjust for this may not be observed. If the MAR assumption does not hold, the estimates will be biased. If starting antidepressants in parallel is common clinical practice, the estimate lacks clinical relevance.</td></tr>
<tr><td colspan="1" rowspan="1">
<strong>Example 2:</strong> A study aims to evaluate the effect of a treatment regimen that comprises an IBI targeting depression in patients undergoing cancer treatment. Some participants may discontinue the intervention (=ICE) due to a deteriorating somatic condition unrelated to the treatment. First, suppose the depressive severity at a fixed time point is of interest (e.g., 3 months after randomization). One may model the missing assessments by focusing on the hypothetical scenario in which individuals could have continued the treatment (<em><span class="text-underline">hypothetical strategy</span></em>). It is necessary to assume that the available information collected among individuals who completed the IBI is sufficient to recover the symptom course under this hypothetical scenario. The estimate quantifies a scenario in which the somatic condition did not deteriorate. Second, researchers could also try to follow up with individuals despite their deteriorating somatic symptoms and consider deteriorations followed by discontinuation a natural characteristic of the target population (<em><span class="text-underline">treatment policy strategy</span></em>). The latter approach assumes that individuals can benefit from the psychotherapeutic techniques they learn when working with IBI, even after they discontinue the treatment due to the worsening somatic condition. However, this becomes problematic when the worsening somatic condition leads to death. <em>Lastly</em>, one may use a <em><span class="text-underline">while-on-treatment</span></em> approach, focusing on the symptom while individuals are using the treatment.</td></tr>
<tr><td colspan="1" rowspan="1">
<strong>Example 3:</strong> In a trial investigating an IBI for adults with depression, some individuals will report elevated levels of suicidality, necessitating acute inpatient treatment. First, one could treat hospitalization as part of the treatment regimen and attempt to follow up with all participants (<em><span class="text-underline">treatment policy strategy</span></em>). This seems to provide a clinically relevant estimate. However, the resulting estimate is a blend of the IBI and hospitalization. If the hospitalization rates differ between treatment arms, problems can arise in interpreting the effect of the treatment. Alternatively, hospitalization can be defined as a “treatment failure” and used as a component of a composite endpoint (<em><span class="text-underline">composite strategy</span></em>). However, the composite strategy assumes that hospitalization has the same clinical relevance as other “treatment failure” indicators merged in the composite.</td></tr>
<tr><td colspan="1" rowspan="1">
<strong>Example 4:</strong> A study compares an IBI to face-to-face psychotherapy (f2f-PT). The depression severity 12 months after randomization is the endpoint. The stakeholder expected that some participants in the IBI group may start psychotherapy between the end of the IBI and the 12-month assessment (ICE). <em>First</em>, researchers could decide to assess all individuals regardless of whether they have started f2f-PT after the IBI (<em><span class="text-underline">treatment policy strategy</span></em>). This approach would effectively compare IBI with the possibility of face-to-face psychotherapy if needed, to standard f2f-PT. <em>Second</em>, researchers could discard the assessments of individuals who began f2f-PT after IBI and attempt to model a scenario in which these individuals did not access f2f-PT (<em><span class="text-underline">hypothetical strategy</span></em>). Applying the hypothetical strategy can be challenging when no follow-up information is available for individuals without access to f2f-PT. Then, it would be necessary to rely solely on assumptions about symptom development in this hypothetical scenario. If, however, such information is available, one could assume that symptom development is similar to that of those who did not access f2f-PT, although their follow-up measurements suggest that they may have benefited from participating in f2f-PT. The same restriction as in Example 1 applies: if the MAR condition is violated, the estimates will be biased. <em>Third</em>, individuals who entered f2f-PT after IBI could be considered “treatment failures” in a composite measure (<em><span class="text-underline">composite strategy</span></em>). Again, the merged indicators of treatment failure must have the same clinical relevance. <em>Last</em>ly, one could focus on the effect among patients who would use the assigned treatment as intended (i.e., either f2f-PT or IBI without subsequent f2f-PT), regardless of their assigned treatment (principal stratum). However, the researchers need to assume that sufficient data is available to recover the latent strata with sufficient accuracy.</td></tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="Tab3"><h3 class="obj_head">Table 3.</h3>
<div class="caption p"><p>Relation to other important concepts in IBI research</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr><td colspan="1" rowspan="1">
<strong>Intention-to-treat (ITT):</strong> Many IBI trials intend to adhere to the ITT principle. The understanding of an ITT analysis is typically centered around including all randomized patients in the analysis and (b) maintaining random group assignment<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>. However, these characteristics leave ambiguity about the estimated effect without considering (c) the handling of ICEs<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>. Recall our motivating example of treatment discontinuation. Trial A, did not assess individuals after treatment discontinuation, and missing values are imputed targeting a hypothetical strategy. Trial B collects the outcome of all randomized individuals. Both trials adhere to principles (a) and (b). However, they target different estimands, as they handle the ICE differently. This ambiguity can be avoided if the following information is provided: (1) Is the primary endpoint collected from all randomized individuals—even if an ICE occurred? (2) Are measurements affected by an ICE discarded or retained in the analysis? (3) How does the statistical approach used to address missing endpoints account for the ICE?</td></tr>
<tr><td colspan="1" rowspan="1">
<strong>Per-protocol analysis (PPA):</strong> The PPA typically compares patients who have completed the treatment according to specific adherence criteria (e.g., at least 75% of the modules completed, where ‘completed’ in IBI trials normally means that individuals entered the modules and worked with them at a self-selected dose). However, the PPA is likely biased because randomization no longer holds<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>,<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>,<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>. A hypothetical (i.e., impute values of non-adherent individuals as <em>if they were adherent;</em> target population: all randomized individuals) or the principal strata strategy (target population: individuals <em>who would complete the treatment</em>, irrespective of which treatment they are assigned) can address the question of PPA<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>,<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>. Both strategies make strong assumptions but may avoid the biases ingrained in PPA<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. It is an ongoing discussion about which approach is the best<sup>e.g.,</sup>
<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a></sup>.</td></tr>
<tr><td colspan="1" rowspan="1">
<strong>Efficacy and effectiveness:</strong> In psychotherapeutic trials, “efficacy” refers to an effect determined under highly controlled conditions, while “effectiveness” refers to the effect in a real-world clinical setting<sup><a href="#CR63" class="usa-link" aria-describedby="CR63">63</a></sup>. However, focusing exclusively on the conditions under which a trial was conducted without considering the handling of ICE leaves ambiguity<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>,<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>. Consider a trial where clients receive treatment-as-usual (TAU) or access an IBI in addition to TAU. With TAU, we refer to standard, evidence-based care. The trial recruits patients from general practitioners and uses “a diagnosis of depression” as the sole inclusion criterion. The trial is conducted under uncontrolled conditions, suggesting that it is an “effectiveness trial.” However, the endpoints of patients who stopped using the IBI are modeled as if the discontinuation had not occurred. Is it still an effectiveness trial, although the analysis mimics a scenario of fully adherent clients? To avoid ambiguity, the definitions of efficacy and effectiveness trials should focus on the handling of ICEs<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>,<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>.</td></tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section id="Sec5"><h3 class="pmc_sec_title">Treatment policy strategy</h3>
<p id="Par25">The treatment policy strategy considers the ICE part of the treatment<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. Measurements remain informative even after an ICE has occurred, making it essential to collect post-ICE measurements<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. Figure <a href="#Fig1" class="usa-link">1</a>A illustrates the treatment policy strategy.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. The different strategies applied to treatment discontinuation.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368201_41746_2025_1936_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23e/12368201/31f6830eb83f/41746_2025_1936_Fig1_HTML.jpg" loading="lazy" id="d33e869" height="1250" width="792" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The black solid lines indicate behavior until the ICE occurs or until the assessment of the endpoint. <strong>A</strong> Treatment policy strategy: Case 1 (C1) completed treatment and the assessment of the endpoint. C2 and C4 discontinued treatment but completed the endpoint assessment; their measurements are retained because discontinuation is considered part of the treatment regimen. C3 and C5 did not complete the endpoint assessment; therefore, endpoints must be modeled. The model must account for the fact that C3 and C5 discontinued the treatment and that C5 started antidepressants after discontinuation. <strong>B</strong> Hypothetical strategy: C1 completed the treatment and the endpoint assessment. C2 and C3 discontinued the treatment, with C3 completing the endpoint assessment. Given that the trial’s interest in a scenario where discontinuation did not occur, this assessment is non-informative and must be discarded. For both cases, the missing outcomes are modeled to mimic a scenario in which they completed treatment (indicated by gray dashed line). C4 completed treatment but not the assessment. This is “pure” missing data, as it is unrelated to an intercurrent-event (ICE), but still requires modeling. <strong>C</strong> While-on-treatment strategy: C1 completed treatment; therefore, the endpoint assessment is used. C2 and C3 discontinued treatment; thus, only measurements collected before discontinuation are used for analysis. <strong>D</strong> Composite strategy: treatment failure is defined as (<strong>A</strong>) treatment discontinuation or (<strong>B</strong>) less than 50% symptom improvement (composite measure). C1 completed treatment and endpoint assessments; coded as treatment failure if symptom improvement is under 50%. C2 and C3 discontinued treatment. Hence, they are coded as treatment failures. <strong>E</strong> Principal stratum strategy: this analysis focuses on the principal stratum of individuals who <em>would</em> complete both treatments, regardless of assignment (TX1: an IBI focusing on cognitive restructuring; TX2: an IBI focusing on behavioral activation). Solid black lines represent behavior under the assigned treatment; dotted black lines represent non-observable behavior under the non-assigned treatment. C1 completed TX1, but <em>would</em> have discontinued TX2. C2 discontinued TX1, but <em>would</em> have completed TX2. In both C1 and C2, the ICE depends on the assigned treatment. C3 <em>would</em> complete both treatments and is thus part of the target stratum. Since statum membership is not observable, it must be estimated.</p></figcaption></figure><p id="Par26">By including all endpoints, even those affected by an ICE, in the analysis, the interpretation shifts toward the effect of <em>providing access to the IBI</em>, rather than the IBI itself. It quantifies the treatment effect under imperfect adherence.</p>
<p id="Par27">The EMA recommends this strategy for handling treatment discontinuation in pharmacological trials<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. This likely extends to IBI trials. Typically, IBI participants decide for themselves how and with what dose they use the treatment material. Therefore, collecting all endpoints at a pre-defined time point, irrespective of the level of engagement, seems to be the natural approach to consider the self-selected heterogeneity in dosage. This strategy bears challenges. Consider a trial that employs this strategy for parallel treatments. Group differences in the endpoint could emerge (or vanish) because the groups initiate parallel treatments with different likelihoods. However, one must assume that the estimate remains informative. High rates of parallel treatments can mask the ineffectiveness of the main treatment component.</p>
<p id="Par28">The treatment policy strategy aims to minimize the need for assumptions by collecting data from all participants. Participants in IBI trials typically do not attend study centers. This increases the risk of missing endpoints after treatment discontinuation, especially if completing an assessment is tied to the use of the IBI. Without personal contact, individuals may feel less obligated to complete the online assessments. If measurements affected by an ICE are missing, the missing endpoints must be modeled in a way that accounts for the fact that the ICE has occurred<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. Without any information about the post-ICE symptom course, researchers must rely solely on assumptions, such as that the post-discontinuation symptom course parallels that of patients in the control group<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>,<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. These assumptions can typically not be verified. Researchers should therefore collect data that is as complete as possible. Thus, strategies to reduce missing values are needed<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>,<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. Resources on the treatment policy strategy are available<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>,<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>,<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Hypothetical strategy</h3>
<p id="Par29">The hypothetical strategy estimates the treatment effect for a well-defined <em>what-if</em> scenario, assuming that the ICE did (or did not) occur<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. Thus, it is impossible to derive a meaningful estimate using observed measurements affected by an ICE. Instead, the endpoints affected by an ICE are modeled in a manner that attempts to mimic the endpoints that would have occurred in the hypothetical scenario<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>.</p>
<p id="Par30">Figure <a href="#Fig1" class="usa-link">1</a>B illustrates this strategy. The hypothetical strategy shifts the interpretation of the estimate towards an effect that <em>would have been observed if discontinuation had not occurred</em>. The strategy relies on two key assumptions: <em>First</em>, the hypothetical scenario is clinically meaningful<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. <em>Second</em>, given all available data, the symptom course in the hypothetical scenario can be predicted<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. Both are often questionable, especially when the rates with which ICEs occur are large (e.g., discontinuation in IBI trials); therefore, caution is needed. If used, the underlying assumptions must be reported<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>.</p>
<p id="Par31">The following example illustrates possible challenges. A study aims to estimate the effect of a scenario in which all participants complete the IBI (i.e., work with all modules in the intended timeframe). To achieve this goal, one must assume that data from individuals who completed IBI is sufficient to estimate the symptom trajectories of those who discontinued treatment as if they had continued treatment (i.e., the <em>missing-at-random assumption</em>, MAR). However, individuals may discontinue the IBI due to dissatisfaction or deteriorating symptoms, and may differ in other characteristics from completers. Therefore, the available information might be insufficient (i.e., we did not collect all relevant covariates) to recover symptom trajectories with continued treatment. The MAR estimates will be biased and may not generalize to real-world settings, particularly when attrition rates are high.</p>
<p id="Par32">The hypothetical strategy typically relies on some variant of multiple imputations; however, other approaches exist. Several resources are available<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>,<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>.</p></section><section id="Sec7"><h3 class="pmc_sec_title">While-on-treatment strategy</h3>
<p id="Par33">The <em>while-on-treatment</em> strategy assumes that measurements collected before the ICE occurred contain all relevant information. Measurements after the ICE are irrelevant<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>.</p>
<p id="Par34">Figure <a href="#Fig1" class="usa-link">1</a>C illustrates this strategy. The strategy yields an estimate that reflects the treatment effects up to the point at which an ICE occurs.</p>
<p id="Par35">It is typically less relevant for evaluating the effects of IBI treatment. However, it can be used to assess safety-related aspects, such as the rate of suicides, while following the assigned treatment. However, some aspects warrant attention. First, the strategy may provide an incomplete picture of all adverse events that occur in the context of the treatment<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>. In particular, the strategy fails to detect adverse events occurring immediately after discontinuation, such as hospitalization or suicide, which could be a consequence of an ineffective treatment. Second, if people in one treatment arm tend to discontinue the treatment earlier, and the risk of adverse events increases over time, event rates may appear lower due to the lower time on treatment. The interpretability of the between-group differences in rates of adverse events becomes misleading. Therefore, a safety assessment of an IBI should combine the while-on-treatment strategy with assessments collected after discontinuation<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>. Interested readers will find more information elsewhere<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Composite strategy</h3>
<p id="Par36">A composite measure is a single outcome variable that combines two or more endpoints<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. The composite strategy considers the ICE part of the endpoint.</p>
<p id="Par37">Figure <a href="#Fig1" class="usa-link">1</a>D illustrates the strategy. The composite strategy shifts the interpretation towards an effect that is a mixture of different components. Consequently, the strategy assumes that the composite measure offers a meaningful interpretation. In particular, it assumes that the components have similar clinical relevance (a limitation that applies to all composite endpoints)<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>.</p>
<p id="Par38">The following example illustrates the interpretative challenges that can emerge when this assumption is violated. Consider two trials that classify a treatment as a failure if (a) there was no reduction in suicidal ideation or (b) hospitalization was required due to suicidal ideation (e.g., rate of treatment failures is the endpoint). Both studies report treatment failure rates of 15%. In study A, 95% of failures were due to no reduction in suicidal ideation, and 5% were due to hospitalization. Study B reports reversed rates. Claiming that both IBIs are equally effective is misleading. Thus, it is essential to report the rate of individual components or to apply appropriate weighting<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>. Further problems arise when the likelihood of certain components differs across treatment arms. Consider a trial that compares antidepressants against an IBI. In the antidepressant arm, treatment discontinuation may result from physiological adverse events that can’t occur in IBIs. Thus, the reasons why the ICE occurred must be considered. Composite strategies may fall short of meeting regulatory expectations. Therefore, even when employing a composite strategy, collecting post-ICE data is advisable. More information is provided elsewhere<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Principal stratum strategy</h3>
<p id="Par39">The principal stratum strategy aims to quantify the treatment effect within the latent stratum of individuals who would (or would not) experience an ICE, regardless of the assigned treatment<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. For instance, in a two-arm trial, one could be interested in the effect among individuals who <em>would</em> complete both treatments, irrespective of which treatment arm they are assigned (see ref. <sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup> for further examples)<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>. Alternatively, one may focus on individuals who would complete the IBI if assigned to the IBI. Thus, the stratum is defined based on how individuals <em>would</em> behave under different treatments<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>.</p>
<p id="Par40">Figure <a href="#Fig1" class="usa-link">1</a>E illustrates the strategy. This interpretation of the treatment effects shifts towards the latent population of individuals defined by the (non-)occurrence of the ICE. The estimate no longer quantifies the effect among all randomized individuals<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>.</p>
<p id="Par41">In theory, this strategy can address clinically relevant questions, such as which treatment yields longer-lasting effects among individuals who <em>would</em> complete both treatments. Beyond the fact that it can be challenging to define what completion means in IBI trials (see Table <a href="#Tab1" class="usa-link">1</a>), it is impossible to observe if an individual will experience the ICE under both treatments. Untestable assumptions are necessary when determining whether an individual belongs to the stratum of interest<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>. One may attempt to model stratum membership using baseline variables<sup><a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>. However, it is impossible to identify stratum membership without error; the statistical analysis must take this into account<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>.</p>
<p id="Par42">Kahan et al. discuss rare instances in which strata appear naturally<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. Consider a study comparing guided versus unguided IBI. Some individuals discontinue the treatment before learning their assigned trial arm. Since discontinuation is unrelated to the treatment, excluding them from the analysis won’t introduce bias<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. The interpretation shifts toward the subset of individuals <em>who would always start the assigned treatment</em> (=the principal stratum)<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. Guidance on appropriate statistical approaches is provided elsewhere<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>.</p></section></section><section id="Sec10"><h2 class="pmc_sec_title">Two examples</h2>
<p id="Par43">Several applications of the framework to pharmacological treatments have been published<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>–<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>. Supplementary Tables <a href="#MOESM1" class="usa-link">1</a> and <a href="#MOESM1" class="usa-link">2</a> present two fictitious examples of IBI trials. They are not intended as best-practice examples, but rather to illustrate the principles of the addendum. The example follows the template to describe trials provided by Ratitch et al.<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par44">This manuscript introduced the ICH E9(R1) addendum to IBI researchers. The addendum prompts prioritizing the collection of measurements vital for answering the clinical question and anticipating how ICEs impair the availability of needed measurements<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. When ICEs are anticipated, trial design and statistical approach can be aligned to derive informative estimates. Trial protocols should report the targeted estimand<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>,<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a></sup>. Reports of completed trials should provide sufficient detail to derive the estimand<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>,<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. This includes describing estimated effects with precise language. Instead of claiming that the “IBI was effective,” one might report that “group differences reflect the effect that <em>could</em> be achieved if all individuals <em>would be</em> compliant” when the hypothetical strategy was employed<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>.</p>
<p id="Par45">Standardized reporting of estimands will facilitate the synthesis of findings in meta-analyses<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>. Currently, the lack of clarity in reporting estimands hampers systematic evaluations of how estimands explain between-study heterogeneity<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>,<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. To increase understanding of estimands, helpful teaching materials have been published<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>,<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>.</p>
<p id="Par46">While this manuscript focuses on parallel group trials, the framework extends to factorial designs<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>, cluster randomized trials<sup><a href="#CR49" class="usa-link" aria-describedby="CR49">49</a></sup>, and non-inferiority and equivalence trials<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>,<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>–<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a></sup>. It should also be considered in face-to-face psychotherapy trials.</p></section><section id="Sec12"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12368201/bin/41746_2025_1936_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (151.2KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Open access funding provided by Freie Universität Berlin.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>M.H. and L.S. drafted the manuscript text and prepared the figures and examples. P.Z., J.B. and C.K. reviewed and revised the initial draft. All authors reviewed the submitted version of the manuscript. Once the manuscript was drafted, we used ChatGPT, Deepl, and Grammarly to improve the quality and conciseness of the language.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open Access funding enabled and organized by Projekt DEAL.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analyzed during the current study.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par47">The authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="sec13"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41746-025-01936-0.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>ICH. ICH harmonized guideline: Addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials E9(R1). (2019).</cite>
</li>
<li id="CR2">
<span class="label">2.</span><cite>Lundberg, I., Johnson, R. &amp; Stewart, B. M. What is your estimand? Defining the target quantity connects statistical evidence to theory. <em>Am. Sociol. Rev.</em><strong>86</strong>, 532–565 (2021).</cite> [<a href="https://scholar.google.com/scholar_lookup?Lundberg,%20I.,%20Johnson,%20R.%20&amp;%20Stewart,%20B.%20M.%20What%20is%20your%20estimand?%20Defining%20the%20target%20quantity%20connects%20statistical%20evidence%20to%20theory.%20Am.%20Sociol.%20Rev.86,%20532%E2%80%93565%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Mallinckrodt, C. H., Molenberghs, G., Lipkovich, I. &amp; Ratitch, B. Estimands, Estimators and Sensitivity Analysis in Clinical Trials. CRC Press, Taylor and Francis Group, 2020.</cite> [<a href="https://scholar.google.com/scholar_lookup?Mallinckrodt,%20C.%20H.,%20Molenberghs,%20G.,%20Lipkovich,%20I.%20&amp;%20Ratitch,%20B.%20Estimands,%20Estimators%20and%20Sensitivity%20Analysis%20in%20Clinical%20Trials.%20CRC%20Press,%20Taylor%20and%20Francis%20Group,%202020." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Kahan, B. C., Cro, S., Li, F. &amp; Harhay, M. O. Eliminating ambiguous treatment effects using estimands. <em>Am. J. Epidemiol.</em><strong>192</strong>, 987–994 (2023).
</cite> [<a href="https://doi.org/10.1093/aje/kwad036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10236519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36790803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kahan,%20B.%20C.,%20Cro,%20S.,%20Li,%20F.%20&amp;%20Harhay,%20M.%20O.%20Eliminating%20ambiguous%20treatment%20effects%20using%20estimands.%20Am.%20J.%20Epidemiol.192,%20987%E2%80%93994%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Kahan, B. C., Hindley, J., Edwards, M., Cro, S. &amp; Morris, T. P. The estimands framework: a primer on the ICH E9(R1) addendum. <em>BMJ</em> e076316 10.1136/bmj-2023-076316 (2024).</cite> [<a href="https://doi.org/10.1136/bmj-2023-076316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10802140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38262663/" class="usa-link">PubMed</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Pohl, M. et al. Estimands—a basic element for clinical trials. Part 29 of a series on evaluation of scientific publications. <em>Dtsch. Ärztebl. Int</em>. 10.3238/arztebl.m2021.0373 (2021).</cite> [<a href="https://doi.org/10.3238/arztebl.m2021.0373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8962508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34857075/" class="usa-link">PubMed</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Mallinckrodt, C. H. et al. Aligning estimators with estimands in clinical trials: putting the ICH E9(R1) guidelines into practice. <em>Ther. Innov. Regul. Sci.</em><strong>54</strong>, 353–364 (2020).
</cite> [<a href="https://doi.org/10.1007/s43441-019-00063-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32072593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mallinckrodt,%20C.%20H.%20et%20al.%20Aligning%20estimators%20with%20estimands%20in%20clinical%20trials:%20putting%20the%20ICH%20E9(R1)%20guidelines%20into%20practice.%20Ther.%20Innov.%20Regul.%20Sci.54,%20353%E2%80%93364%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Ratitch, B. et al. Choosing estimands in clinical trials: putting the ICH E9(R1) into practice. <em>Ther. Innov. Regul. Sci.</em><strong>54</strong>, 324–341 (2020).
</cite> [<a href="https://doi.org/10.1007/s43441-019-00061-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32072573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ratitch,%20B.%20et%20al.%20Choosing%20estimands%20in%20clinical%20trials:%20putting%20the%20ICH%20E9(R1)%20into%20practice.%20Ther.%20Innov.%20Regul.%20Sci.54,%20324%E2%80%93341%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Ratitch, B. et al. Defining efficacy estimands in clinical trials: examples illustrating ICH E9(R1) guidelines. <em>Ther. Innov. Regul. Sci.</em><strong>54</strong>, 370–384 (2020).
</cite> [<a href="https://doi.org/10.1007/s43441-019-00065-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32072586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ratitch,%20B.%20et%20al.%20Defining%20efficacy%20estimands%20in%20clinical%20trials:%20examples%20illustrating%20ICH%20E9(R1)%20guidelines.%20Ther.%20Innov.%20Regul.%20Sci.54,%20370%E2%80%93384%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Akacha, M. et al. Estimands—What they are and why they are important for pharmacometricians. <em>CPT Pharmacomet. Syst. Pharmacol.</em><strong>10</strong>, 279–282 (2021).</cite> [<a href="https://doi.org/10.1002/psp4.12617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8090974/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33951755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akacha,%20M.%20et%20al.%20Estimands%E2%80%94What%20they%20are%20and%20why%20they%20are%20important%20for%20pharmacometricians.%20CPT%20Pharmacomet.%20Syst.%20Pharmacol.10,%20279%E2%80%93282%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Fu, R., Li, H., Wang, X., Shou, Q. &amp; Wang, W. W. B. Application of estimand framework in ICH E9 (R1) to vaccine trials. <em>J. Biopharm. Stat.</em><strong>33</strong>, 502–513 (2023).
</cite> [<a href="https://doi.org/10.1080/10543406.2023.2197040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37012654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu,%20R.,%20Li,%20H.,%20Wang,%20X.,%20Shou,%20Q.%20&amp;%20Wang,%20W.%20W.%20B.%20Application%20of%20estimand%20framework%20in%20ICH%20E9%20(R1)%20to%20vaccine%20trials.%20J.%20Biopharm.%20Stat.33,%20502%E2%80%93513%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>De Silva, A. P., Leslie, K., Braat, S. &amp; Grobler, A. C. Application of the estimand framework to anesthesia trials. <em>Anesthesiology</em><strong>141</strong>, 13–23 (2024).
</cite> [<a href="https://doi.org/10.1097/ALN.0000000000004966" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38743905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Silva,%20A.%20P.,%20Leslie,%20K.,%20Braat,%20S.%20&amp;%20Grobler,%20A.%20C.%20Application%20of%20the%20estimand%20framework%20to%20anesthesia%20trials.%20Anesthesiology141,%2013%E2%80%9323%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Yassi, N., Hayward, K. S., Campbell, B. C. V. &amp; Churilov, L. Use of the estimand framework to manage the disruptive effects of COVID-19 on stroke clinical trials. <em>Stroke</em><strong>52</strong>, 3739–3747 (2021).
</cite> [<a href="https://doi.org/10.1161/STROKEAHA.121.036537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8547578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34587797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yassi,%20N.,%20Hayward,%20K.%20S.,%20Campbell,%20B.%20C.%20V.%20&amp;%20Churilov,%20L.%20Use%20of%20the%20estimand%20framework%20to%20manage%20the%20disruptive%20effects%20of%20COVID-19%20on%20stroke%20clinical%20trials.%20Stroke52,%203739%E2%80%933747%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Aroda, V. R. et al. Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: the PIONEER 1 randomized clinical trial as an example. <em>Diabetes Obes. Metab.</em><strong>21</strong>, 2203–2210 (2019).
</cite> [<a href="https://doi.org/10.1111/dom.13804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6771751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31168921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aroda,%20V.%20R.%20et%20al.%20Incorporating%20and%20interpreting%20regulatory%20guidance%20on%20estimands%20in%20diabetes%20clinical%20trials:%20the%20PIONEER%201%20randomized%20clinical%20trial%20as%20an%20example.%20Diabetes%20Obes.%20Metab.21,%202203%E2%80%932210%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Jin, M. &amp; Liu, G. Estimand framework: delineating what to be estimated with clinical questions of interest in clinical trials. <em>Contemp. Clin. Trials</em><strong>96</strong>, 106093 (2020).
</cite> [<a href="https://doi.org/10.1016/j.cct.2020.106093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32777382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin,%20M.%20&amp;%20Liu,%20G.%20Estimand%20framework:%20delineating%20what%20to%20be%20estimated%20with%20clinical%20questions%20of%20interest%20in%20clinical%20trials.%20Contemp.%20Clin.%20Trials96,%20106093%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Cro, S. et al. Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool. <em>Trials</em><strong>24</strong>, 443 (2023).
</cite> [<a href="https://doi.org/10.1186/s13063-023-07469-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10324181/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37408080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cro,%20S.%20et%20al.%20Starting%20a%20conversation%20about%20estimands%20with%20public%20partners%20involved%20in%20clinical%20trials:%20a%20co-developed%20tool.%20Trials24,%20443%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Keene, O. N., Wright, D., Phillips, A. &amp; Wright, M. Why ITT analysis is not always the answer for estimating treatment effects in clinical trials. <em>Contemp. Clin. Trials</em><strong>108</strong>, 106494 (2021).
</cite> [<a href="https://doi.org/10.1016/j.cct.2021.106494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8234249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34186242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Keene,%20O.%20N.,%20Wright,%20D.,%20Phillips,%20A.%20&amp;%20Wright,%20M.%20Why%20ITT%20analysis%20is%20not%20always%20the%20answer%20for%20estimating%20treatment%20effects%20in%20clinical%20trials.%20Contemp.%20Clin.%20Trials108,%20106494%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Han, S. &amp; Zhou, X. Defining estimands in clinical trials: a unified procedure. <em>Stat. Med.</em><strong>42</strong>, 1869–1887 (2023).
</cite> [<a href="https://doi.org/10.1002/sim.9702" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36883638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han,%20S.%20&amp;%20Zhou,%20X.%20Defining%20estimands%20in%20clinical%20trials:%20a%20unified%20procedure.%20Stat.%20Med.42,%201869%E2%80%931887%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Fiero, M. H. et al. Demystifying the estimand framework: a case study using patient-reported outcomes in oncology. <em>Lancet Oncol.</em><strong>21</strong>, e488–e494 (2020).
</cite> [<a href="https://doi.org/10.1016/S1470-2045(20)30319-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33002444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fiero,%20M.%20H.%20et%20al.%20Demystifying%20the%20estimand%20framework:%20a%20case%20study%20using%20patient-reported%20outcomes%20in%20oncology.%20Lancet%20Oncol.21,%20e488%E2%80%93e494%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Cro, S. et al. Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands. <strong>378</strong><em>,</em> e070146 (2022).</cite> [<a href="https://doi.org/10.1136/bmj-2022-070146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9396446/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35998928/" class="usa-link">PubMed</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>EMA/CHMP/185423/2010. Guideline on clinical investigation of medicinal products in the treatment of depression.</cite>
</li>
<li id="CR22">
<span class="label">22.</span><cite>Hopewell, S. et al. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. <em>BMJ</em><strong>389</strong>, e081124 (2025) .</cite> [<a href="https://doi.org/10.1136/bmj-2024-081124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11995452/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40228832/" class="usa-link">PubMed</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Drury, T., Abellan, J. J., Best, N. &amp; White, I. R. Estimation of treatment policy estimands for continuous outcomes using off-treatment sequential multiple imputation. <em>Pharm. Stat.</em><strong>23</strong>, 1144–1155 (2024).
</cite> [<a href="https://doi.org/10.1002/pst.2411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11602932/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39099192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drury,%20T.,%20Abellan,%20J.%20J.,%20Best,%20N.%20&amp;%20White,%20I.%20R.%20Estimation%20of%20treatment%20policy%20estimands%20for%20continuous%20outcomes%20using%20off-treatment%20sequential%20multiple%20imputation.%20Pharm.%20Stat.23,%201144%E2%80%931155%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Bell, J. et al. Estimation methods for estimands using the treatment policy strategy; a simulation study based on the PIONEER 1 trial. <em>Pharm. Stat.</em><strong>24</strong>, e2472 (2025).
</cite> [<a href="https://doi.org/10.1002/pst.2472" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40045733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bell,%20J.%20et%20al.%20Estimation%20methods%20for%20estimands%20using%20the%20treatment%20policy%20strategy;%20a%20simulation%20study%20based%20on%20the%20PIONEER%201%20trial.%20Pharm.%20Stat.24,%20e2472%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Wang, S. &amp; Hu, H. Impute the missing data using retrieved dropouts. <em>BMC Med. Res. Methodol.</em><strong>22</strong>, 82 (2022).
</cite> [<a href="https://doi.org/10.1186/s12874-022-01509-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8962050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35350976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20S.%20&amp;%20Hu,%20H.%20Impute%20the%20missing%20data%20using%20retrieved%20dropouts.%20BMC%20Med.%20Res.%20Methodol.22,%2082%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Fletcher, C. et al. Marking 2-years of new thinking in clinical trials: the estimand journey. <em>Ther. Innov. Regul. Sci.</em><strong>56</strong>, 637–650 (2022).
</cite> [<a href="https://doi.org/10.1007/s43441-022-00402-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9035309/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35462609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fletcher,%20C.%20et%20al.%20Marking%202-years%20of%20new%20thinking%20in%20clinical%20trials:%20the%20estimand%20journey.%20Ther.%20Innov.%20Regul.%20Sci.56,%20637%E2%80%93650%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Mallinckrod, C. &amp; Lipkovich, I. <em>Analyzing Longitudinal Clinical Trial Data: A Practical Guide</em> (CRC PRESS, 2020).</cite>
</li>
<li id="CR28">
<span class="label">28.</span><cite>Carpenter, J. R., Roger, J. H. &amp; Kenward, M. G. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation. <em>J. Biopharm. Stat.</em><strong>23</strong>, 1352–1371 (2013).
</cite> [<a href="https://doi.org/10.1080/10543406.2013.834911" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24138436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carpenter,%20J.%20R.,%20Roger,%20J.%20H.%20&amp;%20Kenward,%20M.%20G.%20Analysis%20of%20longitudinal%20trials%20with%20protocol%20deviation:%20a%20framework%20for%20relevant,%20accessible%20assumptions,%20and%20inference%20via%20multiple%20imputation.%20J.%20Biopharm.%20Stat.23,%201352%E2%80%931371%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Mallinckrodt, C. H. <em>Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practical Guide</em> (Cambridge University Press, 2013). 10.1017/CBO9781139381666.</cite>
</li>
<li id="CR30">
<span class="label">30.</span><cite>Little, R. J. et al. The prevention and treatment of missing data in clinical trials. <em>N. Engl. J. Med.</em><strong>367</strong>, 1355–1360 (2012).
</cite> [<a href="https://doi.org/10.1056/NEJMsr1203730" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3771340/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23034025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Little,%20R.%20J.%20et%20al.%20The%20prevention%20and%20treatment%20of%20missing%20data%20in%20clinical%20trials.%20N.%20Engl.%20J.%20Med.367,%201355%E2%80%931360%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Carpenter, J. R. <em>Multiple Imputation and Its Application</em> (John Wiley &amp; Sons, Inc., 2023).</cite>
</li>
<li id="CR32">
<span class="label">32.</span><cite>Wang, Y. et al. Statistical methods for handling missing data to align with treatment policy strategy. <em>Pharm. Stat.</em><strong>22</strong>, 650–670 (2023).
</cite> [<a href="https://doi.org/10.1002/pst.2299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36970810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20Y.%20et%20al.%20Statistical%20methods%20for%20handling%20missing%20data%20to%20align%20with%20treatment%20policy%20strategy.%20Pharm.%20Stat.22,%20650%E2%80%93670%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Olarte Parra, C., Daniel, R. M. &amp; Bartlett, J. W. Hypothetical estimands in clinical trials: a unification of causal inference and missing data methods. <em>Stat. Biopharm. Res.</em><strong>15</strong>, 421–432 (2023).
</cite> [<a href="https://doi.org/10.1080/19466315.2022.2081599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10228513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37260584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Olarte%20Parra,%20C.,%20Daniel,%20R.%20M.%20&amp;%20Bartlett,%20J.%20W.%20Hypothetical%20estimands%20in%20clinical%20trials:%20a%20unification%20of%20causal%20inference%20and%20missing%20data%20methods.%20Stat.%20Biopharm.%20Res.15,%20421%E2%80%93432%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Yang, F., Wittes, J. &amp; Pitt, B. Beware of on-treatment safety analyses. <em>Clin. Trials</em><strong>16</strong>, 63–70 (2019).
</cite> [<a href="https://doi.org/10.1177/1740774518812774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30445833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang,%20F.,%20Wittes,%20J.%20&amp;%20Pitt,%20B.%20Beware%20of%20on-treatment%20safety%20analyses.%20Clin.%20Trials16,%2063%E2%80%9370%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Ting, N., Huang, L., Deng, Q. &amp; Cappelleri, J. C. Average response over time as estimand: an alternative implementation of the while on treatment strategy. <em>Stat. Biosci.</em><strong>13</strong>, 479–494 (2021).</cite> [<a href="https://scholar.google.com/scholar_lookup?Ting,%20N.,%20Huang,%20L.,%20Deng,%20Q.%20&amp;%20Cappelleri,%20J.%20C.%20Average%20response%20over%20time%20as%20estimand:%20an%20alternative%20implementation%20of%20the%20while%20on%20treatment%20strategy.%20Stat.%20Biosci.13,%20479%E2%80%93494%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Rauch, G., Schüler, S. &amp; Kieser, M. <em>Planning and Analyzing Clinical Trials with Composite Endpoints</em> (Springer Nature, 2018).</cite>
</li>
<li id="CR37">
<span class="label">37.</span><cite>Hara, H. et al. Statistical methods for composite endpoints. <em>EuroIntervention</em><strong>16</strong>, e1484–e1495 (2021).
</cite> [<a href="https://doi.org/10.4244/EIJ-D-19-00953" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9724993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32338610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hara,%20H.%20et%20al.%20Statistical%20methods%20for%20composite%20endpoints.%20EuroIntervention16,%20e1484%E2%80%93e1495%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Bornkamp, B. et al. Principal stratum strategy: potential role in drug development. <em>Pharm. Stat.</em><strong>20</strong>, 737–751 (2021).
</cite> [<a href="https://doi.org/10.1002/pst.2104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33624407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bornkamp,%20B.%20et%20al.%20Principal%20stratum%20strategy:%20potential%20role%20in%20drug%20development.%20Pharm.%20Stat.20,%20737%E2%80%93751%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Lipkovich, I. et al. Using principal stratification in analysis of clinical trials. <em>Stat. Med.</em><strong>41</strong>, 3837–3877 (2022).
</cite> [<a href="https://doi.org/10.1002/sim.9439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35851717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lipkovich,%20I.%20et%20al.%20Using%20principal%20stratification%20in%20analysis%20of%20clinical%20trials.%20Stat.%20Med.41,%203837%E2%80%933877%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Kahan, B. C., White, I. R., Edwards, M. &amp; Harhay, M. O. Using modified intention-to-treat as a principal stratum estimator for failure to initiate treatment. <em>Clin. Trials</em><strong>20</strong>, 269–275 (2023).
</cite> [<a href="https://doi.org/10.1177/17407745231160074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10262320/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36916466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kahan,%20B.%20C.,%20White,%20I.%20R.,%20Edwards,%20M.%20&amp;%20Harhay,%20M.%20O.%20Using%20modified%20intention-to-treat%20as%20a%20principal%20stratum%20estimator%20for%20failure%20to%20initiate%20treatment.%20Clin.%20Trials20,%20269%E2%80%93275%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Leuchs, A.-K., Zinserling, J., Brandt, A., Wirtz, D. &amp; Benda, N. Choosing appropriate estimands in clinical trials. <em>Ther. Innov. Regul. Sci.</em><strong>49</strong>, 584–592 (2015).
</cite> [<a href="https://doi.org/10.1177/2168479014567317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30222440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leuchs,%20A.-K.,%20Zinserling,%20J.,%20Brandt,%20A.,%20Wirtz,%20D.%20&amp;%20Benda,%20N.%20Choosing%20appropriate%20estimands%20in%20clinical%20trials.%20Ther.%20Innov.%20Regul.%20Sci.49,%20584%E2%80%93592%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Sepin, J. et al. Applying the principal stratum strategy in equivalence trials: a case study. <em>Pharm. Stat.</em><strong>24</strong>, e70008 (2025).
</cite> [<a href="https://doi.org/10.1002/pst.70008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40326608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sepin,%20J.%20et%20al.%20Applying%20the%20principal%20stratum%20strategy%20in%20equivalence%20trials:%20a%20case%20study.%20Pharm.%20Stat.24,%20e70008%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Mitroiu, M., Teerenstra, S., Oude Rengerink, K., Pétavy, F. &amp; Roes, K. C. B. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9 (R1) estimands framework. <em>Pharm. Stat.</em><strong>21</strong>, 1037–1057 (2022).
</cite> [<a href="https://doi.org/10.1002/pst.2214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9543408/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35678545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mitroiu,%20M.,%20Teerenstra,%20S.,%20Oude%20Rengerink,%20K.,%20P%C3%A9tavy,%20F.%20&amp;%20Roes,%20K.%20C.%20B.%20Estimation%20of%20treatment%20effects%20in%20short-term%20depression%20studies.%20An%20evaluation%20based%20on%20the%20ICH%20E9%20(R1)%20estimands%20framework.%20Pharm.%20Stat.21,%201037%E2%80%931057%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Lynggaard, H. et al. Applying the estimand framework to clinical pharmacology trials with a case study in bioequivalence. <em>Br. J. Clin. Pharmacol.</em><strong>91</strong>, 310–324 (2025).
</cite> [<a href="https://doi.org/10.1111/bcp.16347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11773105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39587445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lynggaard,%20H.%20et%20al.%20Applying%20the%20estimand%20framework%20to%20clinical%20pharmacology%20trials%20with%20a%20case%20study%20in%20bioequivalence.%20Br.%20J.%20Clin.%20Pharmacol.91,%20310%E2%80%93324%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Lynggaard, H. et al. Principles and recommendations for incorporating estimands into clinical study protocol templates. <em>Trials</em><strong>23</strong>, 685 (2022).
</cite> [<a href="https://doi.org/10.1186/s13063-022-06515-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9389514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35986349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lynggaard,%20H.%20et%20al.%20Principles%20and%20recommendations%20for%20incorporating%20estimands%20into%20clinical%20study%20protocol%20templates.%20Trials23,%20685%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Kahan, B. C., Morris, T. P., White, I. R., Carpenter, J. &amp; Cro, S. Estimands in published protocols of randomised trials: urgent improvement needed. <em>Trials</em><strong>22</strong>, 686 (2021).
</cite> [<a href="https://doi.org/10.1186/s13063-021-05644-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8500821/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34627347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kahan,%20B.%20C.,%20Morris,%20T.%20P.,%20White,%20I.%20R.,%20Carpenter,%20J.%20&amp;%20Cro,%20S.%20Estimands%20in%20published%20protocols%20of%20randomised%20trials:%20urgent%20improvement%20needed.%20Trials22,%20686%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>ICH E9(R1) Expert Working Group. ICH E9(R1) Estimands and Sensitivity Analysis in Clinical Trials Training Module 1: Summary. Addendum to ICH E9 – Statistical Principles for Clinical Trials. (2021).</cite>
</li>
<li id="CR48">
<span class="label">48.</span><cite>Kahan, B. C., Morris, T. P., Goulão, B. &amp; Carpenter, J. Estimands for factorial trials. <em>Stat. Med.</em><strong>41</strong>, 4299–4310 (2022).
</cite> [<a href="https://doi.org/10.1002/sim.9510" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9542167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35751568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kahan,%20B.%20C.,%20Morris,%20T.%20P.,%20Goul%C3%A3o,%20B.%20&amp;%20Carpenter,%20J.%20Estimands%20for%20factorial%20trials.%20Stat.%20Med.41,%204299%E2%80%934310%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Kahan, B. C., Li, F., Copas, A. J. &amp; Harhay, M. O. Estimands in cluster-randomized trials: choosing analyses that answer the right question. <em>Int. J. Epidemiol.</em><strong>52</strong>, 107–118 (2023).
</cite> [<a href="https://doi.org/10.1093/ije/dyac131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9908044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35834775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kahan,%20B.%20C.,%20Li,%20F.,%20Copas,%20A.%20J.%20&amp;%20Harhay,%20M.%20O.%20Estimands%20in%20cluster-randomized%20trials:%20choosing%20analyses%20that%20answer%20the%20right%20question.%20Int.%20J.%20Epidemiol.52,%20107%E2%80%93118%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Rehal, S., Cro, S., Phillips, P. P., Fielding, K. &amp; Carpenter, J. R. Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: a tuberculosis case study. <em>Clin. Trials</em><strong>20</strong>, 497–506 (2023).
</cite> [<a href="https://doi.org/10.1177/17407745231176773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10504812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37277978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rehal,%20S.,%20Cro,%20S.,%20Phillips,%20P.%20P.,%20Fielding,%20K.%20&amp;%20Carpenter,%20J.%20R.%20Handling%20intercurrent%20events%20and%20missing%20data%20in%20non-inferiority%20trials%20using%20the%20estimand%20framework:%20a%20tuberculosis%20case%20study.%20Clin.%20Trials20,%20497%E2%80%93506%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Lynggaard, H., Keene, O. N., Mütze, T. &amp; Rehal, S. Applying the estimand framework to non-inferiority trials. <em>Pharm. Stat.</em><strong>23</strong>, 1156–1165 (2024).
</cite> [<a href="https://doi.org/10.1002/pst.2433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11602919/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39115134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lynggaard,%20H.,%20Keene,%20O.%20N.,%20M%C3%BCtze,%20T.%20&amp;%20Rehal,%20S.%20Applying%20the%20estimand%20framework%20to%20non-inferiority%20trials.%20Pharm.%20Stat.23,%201156%E2%80%931165%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Morgan, K. E., White, I. R., Leyrat, C., Stanworth, S. &amp; Kahan, B. C. Applying the estimands framework to non-inferiority trials: guidance on choice of hypothetical estimands for non-adherence and comparison of estimation methods. <em>Stat. Med.</em><strong>44</strong>, e10348 (2025).
</cite> [<a href="https://doi.org/10.1002/sim.10348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11806244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39921280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morgan,%20K.%20E.,%20White,%20I.%20R.,%20Leyrat,%20C.,%20Stanworth,%20S.%20&amp;%20Kahan,%20B.%20C.%20Applying%20the%20estimands%20framework%20to%20non-inferiority%20trials:%20guidance%20on%20choice%20of%20hypothetical%20estimands%20for%20non-adherence%20and%20comparison%20of%20estimation%20methods.%20Stat.%20Med.44,%20e10348%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Montedori, A. et al. Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study. <em>Trials</em><strong>12</strong>, 58 (2011).
</cite> [<a href="https://doi.org/10.1186/1745-6215-12-58" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3055831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21356072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montedori,%20A.%20et%20al.%20Modified%20versus%20standard%20intention-to-treat%20reporting:%20Are%20there%20differences%20in%20methodological%20quality,%20sponsorship,%20and%20findings%20in%20randomized%20trials?%20A%20cross-sectional%20study.%20Trials12,%2058%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Hernán, M. A. &amp; Hernández-Díaz, S. Beyond the intention-to-treat in comparative effectiveness research. <em>Clin. Trials</em><strong>9</strong>, 48–55 (2012).
</cite> [<a href="https://doi.org/10.1177/1740774511420743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3731071/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21948059/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hern%C3%A1n,%20M.%20A.%20&amp;%20Hern%C3%A1ndez-D%C3%ADaz,%20S.%20Beyond%20the%20intention-to-treat%20in%20comparative%20effectiveness%20research.%20Clin.%20Trials9,%2048%E2%80%9355%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Apter, A. et al. Irregular assessment times in pragmatic randomized clinical trials. <em>Trials</em><strong>25</strong>, 841 (2024).
</cite> [<a href="https://doi.org/10.1186/s13063-024-08676-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11660989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39702510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Apter,%20A.%20et%20al.%20Irregular%20assessment%20times%20in%20pragmatic%20randomized%20clinical%20trials.%20Trials25,%20841%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Pullenayegum, E. M. &amp; Scharfstein, D. O. Randomized trials with repeatedly measured outcomes: handling irregular and potentially informative assessment times. <em>Epidemiol. Rev.</em><strong>44</strong>, 121–137 (2022).
</cite> [<a href="https://doi.org/10.1093/epirev/mxac010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10362939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36259969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pullenayegum,%20E.%20M.%20&amp;%20Scharfstein,%20D.%20O.%20Randomized%20trials%20with%20repeatedly%20measured%20outcomes:%20handling%20irregular%20and%20potentially%20informative%20assessment%20times.%20Epidemiol.%20Rev.44,%20121%E2%80%93137%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Luo, Y. et al. Large variation existed in standardized mean difference estimates using different calculation methods in clinical trials. <em>J. Clin. Epidemiol.</em><strong>149</strong>, 89–97 (2022).
</cite> [<a href="https://doi.org/10.1016/j.jclinepi.2022.05.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35654267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo,%20Y.%20et%20al.%20Large%20variation%20existed%20in%20standardized%20mean%20difference%20estimates%20using%20different%20calculation%20methods%20in%20clinical%20trials.%20J.%20Clin.%20Epidemiol.149,%2089%E2%80%9397%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Cumming, G. Cohen’s d needs to be readily interpretable: comment on Shieh (2013). <em>Behav. Res. Methods</em><strong>45</strong>, 968–971 (2013).
</cite> [<a href="https://doi.org/10.3758/s13428-013-0392-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24002988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cumming,%20G.%20Cohen%E2%80%99s%20d%20needs%20to%20be%20readily%20interpretable:%20comment%20on%20Shieh%20(2013).%20Behav.%20Res.%20Methods45,%20968%E2%80%93971%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite><em>Cochrane Handbook for Systematic Reviews of Interventions</em> (Wiley, 2019). 10.1002/9781119536604.</cite>
</li>
<li id="CR60">
<span class="label">60.</span><cite>Leuchs, A., Brandt, A., Zinserling, J. &amp; Benda, N. Disentangling estimands and the intention-to-treat principle. <em>Pharm. Stat.</em><strong>16</strong>, 12–19 (2017).
</cite> [<a href="https://doi.org/10.1002/pst.1791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27910217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leuchs,%20A.,%20Brandt,%20A.,%20Zinserling,%20J.%20&amp;%20Benda,%20N.%20Disentangling%20estimands%20and%20the%20intention-to-treat%20principle.%20Pharm.%20Stat.16,%2012%E2%80%9319%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Keene, O. Adherence, per-protocol effects, and the estimands framework. <em>Pharm. Stat.</em><strong>22</strong>, 1141–1144 (2023).
</cite> [<a href="https://doi.org/10.1002/pst.2326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37477077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Keene,%20O.%20Adherence,%20per-protocol%20effects,%20and%20the%20estimands%20framework.%20Pharm.%20Stat.22,%201141%E2%80%931144%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Hernán, M. A. &amp; Robins, J. M. Per-protocol analyses of pragmatic trials. <em>N. Engl. J. Med.</em><strong>377</strong>, 1391–1398 (2017).
</cite> [<a href="https://doi.org/10.1056/NEJMsm1605385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28976864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hern%C3%A1n,%20M.%20A.%20&amp;%20Robins,%20J.%20M.%20Per-protocol%20analyses%20of%20pragmatic%20trials.%20N.%20Engl.%20J.%20Med.377,%201391%E2%80%931398%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Wirtz, M. Effectiveness im Dorsch Lexikon der Psychologie. (Hogrefe, 2021).</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12368201/bin/41746_2025_1936_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (151.2KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analyzed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from NPJ Digital Medicine are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41746-025-01936-0"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41746_2025_Article_1936.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (751.0 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12368201/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12368201/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368201%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368201/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12368201/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12368201/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40835721/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12368201/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40835721/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12368201/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12368201/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="xiHRQV8qydEkiQvMc6Tf9Grik90udWbvlx0riXiIBS3J0wk0yFibakGwYisw57vH">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
